University of Wollongong
Browse

Effect of a glucagon-like peptide 1 (GLP-1) receptor agonist, liraglutide, on cognition and body weight during antipsychotic treatment

Download (112.42 kB)
journal contribution
posted on 2024-11-15, 02:11 authored by Ilijana Babic, Ashleigh Gorak, Jason Hughes, Martin Engel, Dominic Sellers, Paul ElsePaul Else, Luisa Lufe, Anita-Louise Obeid, Ashleigh Osborne, P Le Mesurier, Nagesh PaiNagesh Pai, Xu-Feng HuangXu-Feng Huang, Katrina GreenKatrina Green
abstract of poster that was presented at the 30th CINP World Congress of Neuropsychopharmacology, 3-5 July, Seoul, Republic of Korea.

History

Citation

Babic, I., Gorak, A., Hughes, J., Engel, M., Sellers, D., Else, P., Lufe, L., Obeid, A. L., Osborne, A., Le Mesurier, P., Pai, N., Huang, X. F. & Weston-Green, K. (2016). Effect of a glucagon-like peptide 1 (GLP-1) receptor agonist, liraglutide, on cognition and body weight during antipsychotic treatment. International Journal of Neuropsychopharmacology, 19 (Suppl. 1), 55-55.

Journal title

The International Journal of Neuropsychopharmacology

Volume

19

Issue

Suppl_1

Pagination

55-55

Publisher website/DOI

Language

English

RIS ID

109146

Usage metrics

    Categories

    Keywords

    health sciences

    Licence

    Copyright - All rights reserved

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC